PCI Biotech initiates pre-clinical research collaboration in siRNA therapeutics NewsKristin EivindvikApril 7, 2015
PCI Biotech announces positive feedback regarding a patent application in vaccination and immunotherapy NewsKristin EivindvikMarch 6, 2015
Completion of the third group in the intra-tumour light dose escalation part of the ENHANCE study NewsKristin EivindvikFebruary 20, 2015
Successful completion of the second dose cohort in the study for patients with inoperable bile duct cancer NewsKristin EivindvikFebruary 6, 2015
PCI Biotech: Successful Investigational New Drug application (IND) review for Amphinex NewsKristin EivindvikJanuary 20, 2015
Fully underwritten rights issue of NOK 70 million - link to prospectus and online subscription NewsKristin EivindvikJanuary 20, 2015
Publication of results showing that the PCI technology can significantly improve vaccination treatment in a melanoma model NewsKristin EivindvikDecember 9, 2014
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 70 million NewsKristin EivindvikDecember 9, 2014
PCI Biotech presenting at DNB Markets Health Care Conference 2014 NewsKristin EivindvikNovember 13, 2014
PCI Biotech presented at the World Vaccine Congress Europe 2014 NewsKristin EivindvikOctober 14, 2014
PCI Biotech to present at SACHS Associates 14th Annual Biotech in Europe Forum NewsKristin EivindvikSeptember 30, 2014
